Scott Leonard-Morgan Director

Scott Leonard-Morgan
Direct line
+44 1624 638364
Isle of Man


Scott has extensive experience in domestic and international mergers and acquisitions, corporate finance and public and private securities offerings.  He works across a wide range of sectors that includes a strong focus on technology and the financial services and payments industries.

Scott has regularly advised LSE Main Market and AIM listed companies, including FTSE 100 companies, and has a wealth of commercial and corporate experience that includes advising boards on internal governance issues.  He has also extensively mentored early stage companies and assisted them with their growth from acorns to oak trees.

In addition to M&A and public securities work, Scott advises in connection with:


  • venture capital and private equity funding
  • loan and debt facilities
  • alternative investments
  • corporate restructurings
  • joint ventures
  • commercial contracts
  • corporate governance
  • Bribery Act protection policies and procedures
  • general corporate and commercial matters.

Key experience


  • Sale of Domantis Limited to GlaxoSmithKline for £210,000,000
  • Flotation of Optos plc on the Official List of the London Stock Exchange
  • Merger of with Betfair
  • Flotation of Wolfson Microelectronics plc on the Official List of the London Stock Exchange
  • Acquisition by Wolfson Microelectronics plc of Sonaptic Limited for £26,000,000
  • Acquisition of etalk Corporation (US) by Autonomy Corporation plc for $93,000,000
  • Sale of QAS Limited to Experian Limited for £110,000,000
  • Negotiating and maintaining large (£100m – £1bn) international construction and project related contracts
  • Advising on $4,000,000,000 revolving credit facility for Vodafone PLC
  • Flotation of Gas Turbine Efficiency plc on the AIM market
  • Advising on $30,000,000,000 EMTN programme for Vodafone PLC, including prospectus supplements and shelf “take-downs”
  • Licencing and development of next generation payment processing projects
  • Advising Regen Therapeutics plc on numerous secondary offerings on AIM
  • Board level training for legal compliance, risk and corporate governance, including anti-bribery and corruption, whistle blowing, risk and ethics matters
  • Multiple venture capital investments (from seed to final round), representing both company and investor side
  • Multiple loan facilities, representing both lenders and borrowers

Contact us

If we can help you with any requirements please call us on +44 1624 638300 or email us your enquiry to